InvestorsObserver
×
News Home

Tenax Therapeutics Inc (TENX) Down 5.04% in Premarket Trading

Monday, February 12, 2024 06:57 AM | InvestorsObserver Analysts

Mentioned in this article

Tenax Therapeutics Inc (TENX) Down 5.04% in Premarket Trading

Tenax Therapeutics Inc (TENX) is lower by Monday morning, with the stock losing -5.04% in pre-market trading to 4.71. TENX's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 111 out of 146 industries, Tenax Therapeutics Inc ranks higher than 5% of stocks. Tenax Therapeutics Inc has fallen 65.17% over the past month, closing at $11.79 on January 15. During this period of time, the stock fell as low as $4.96 and as high as $21.46. TENX has an average analyst recommendation of Strong Buy. The company has an average price target of $440.00.

Overall Score - 31
TENX has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on TENX!
Tenax Therapeutics Inc has a Long-Term Technical rank of 13. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 87% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, TENX ranks better than 69% of stocks.

Important Dates for Investors in TENX:

-Tenax Therapeutics Inc is set to release earnings on 2024-05-12. Over the last 12 months, the company has reported EPS of $-88.80. -We do not have a set dividend date for Tenax Therapeutics Inc at this time. Click Here To Get The Full Report on Tenax Therapeutics Inc (TENX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App